Lasry Marc
NEW YORK, NY
$15m in 9 US stocks at the end of 30 September 2025. The top 10 are 100.0% of the money. It changed about 83.2% of the portfolio this quarter.
Value
$15m
Stocks
9
Top 10 share
100.0%
Turnover
83.2%
What changed this quarter
New
Bought for the first time this quarter.
- XBP Global HoldingsXBP64.9% of the fund
- Hyperion DefiHYPD15.3% of the fund
- Valion BIO2.0% of the fund
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
- Dariohealth2.7% of the fund-95%
- Beyond AirXAIR1.3% of the fund-95%
Sold out
Sold their entire stake.
- PDD Holdings-100%
- Exela Technologies-100%
Holdings
- Dariohealth
- Share
- 2.7%
- Value
- $403,318
- Shares
- 23,246
-95%
- Valion BIO
- Share
- 2.0%
- Value
- $293,734
- Shares
- 101,638
New
- Forge Global HoldingsFRGE
- Share
- 1.3%
- Value
- $192,035
- Shares
- 11,363
Held
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| XBP Global HoldingsXBP | 64.9% | $10m | 12,107,907 | New |
| Hyperion DefiHYPD | 15.3% | $2m | 240,124 | New |
| NextDecadeNEXT | 11.5% | $2m | 254,270 | Held |
| Dariohealth | 2.7% | $403,318 | 23,246 | -95% |
| Valion BIO | 2.0% | $293,734 | 101,638 | New |
| Forge Global HoldingsFRGE | 1.3% | $192,035 | 11,363 | Held |
| Beyond AirXAIR | 1.3% | $189,305 | 81,950 | -95% |
| Orchestra BioMed HoldingsOBIO | 1.0% | $150,955 | 60,869 | Held |
| Rani Therapeutics HoldingsRANI | 0.2% | $31,431 | 62,887 | Held |
Over time and by industry
Value over time
Sep '25
Value is down 15.8% since 30 June 2025.
Where the money is
Technology64.9%
Financial services15.3%
Utilities11.5%
Health care2.5%
Other5.9%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.